Long-Term Mixed Chimerism After Ex Vivo/In Vivo T Cell-Depleted Allogeneic Hematopoietic Cell Transplantation in Patients With Myeloid Neoplasms

In patients who have undergone allogeneic hematopoietic cell transplantation (HCT), myeloid mixed donor chimerism (MC) is a risk factor for disease relapse. In contrast, several studies found favorable outcome in patients with lymphoid MC. Thus far, most studies evaluating MC focused on a short-term...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruhnke, Leo, Stölzel, Friedrich, Oelschlägel, Uta, von Bonin, Malte, Sockel, Katja, Middeke, Jan Moritz, Röllig, Christoph, Jöhrens, Korinna, Schetelig, Johannes, Thiede, Christian, Bornhäuser, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688843/
https://www.ncbi.nlm.nih.gov/pubmed/34950586
http://dx.doi.org/10.3389/fonc.2021.776946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688843/
https://www.ncbi.nlm.nih.gov/pubmed/34950586
http://dx.doi.org/10.3389/fonc.2021.776946

Ejemplares similares